- Systematic review and meta-analysis of 38 studies (30 randomized, 8 observational; 7,494 patients) comparing digital health interventions with standard care after non-cardiac surgery.
- Interventions were grouped by whether a clinician reviewed patient-submitted data and could act on it, versus no such clinician involvement.
- Digital health interventions were associated with fewer readmissions (RR 0.85, 95% CI 0.73-0.99, adjusted p=0.045), ER visits, and major complications, but not all-cause complications or length of stay.
- The readmission reduction was seen with active clinician involvement (RR 0.76, 95% CI 0.64-0.92) but not without it (RR 0.96, 95% CI 0.78-1.18; interaction p=0.029).
Cardiac
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- Systematic review of PubMed and Scopus pooling 23 published studies covering 207 patients with HIT or suspected HIT undergoing cardiopulmonary bypass.
- Iloprost or epoprostenol was given to inhibit platelet function so heparin could be used during bypass, followed by protamine reversal.
- Both agents permitted heparinization and protamine reversal, and norepinephrine was used for prostacyclin-mediated hypotension in 14 of 17 studies (82.3%).
- Transfusion occurred in 58.9% of patients and thrombotic events in 8.2%, with only 1 of 207 (0.5%) thrombosing during bypass itself.
- Systematic review of three randomized controlled trials including 168 adults with type 2 diabetes undergoing cardiac surgery.
- Compared liraglutide added to insulin with insulin alone or placebo, assessing perioperative glucose, variability, insulin adjustments, and hypoglycemia.
- Liraglutide was associated with lower glucose, reduced glycemic variability, and fewer insulin adjustments, with low hypoglycemia, though the abstract reports no effect sizes or p values.
- Nausea and vomiting were more frequent with liraglutide; the authors call the evidence preliminary and call for larger, standardized trials with long-term outcomes.
- Systematic review and meta-analysis of 14 reports of randomized trials (1,773 participants in the primary synthesis), all conducted in China, in adults undergoing cardiac surgery.
- Compared remimazolam-based with propofol-based general anesthesia for induction and maintenance.
- Remimazolam was associated with fewer trial-defined intraoperative hypotension (OR 0.31; 95% CI 0.20-0.47) and bradycardia events (OR 0.20; 95% CI 0.12-0.34), and shorter mechanical ventilation (MD -1.84 hours; 95% CI -2.34 to -1.35).
- Length of stay did not reach significance (MD -0.48 days; 95% CI -0.99 to 0.02; p = 0.06), major morbidity and mortality could not be pooled, and certainty was very low.
- Systematic review and meta-analysis of 104 randomized controlled trials in adults undergoing open or minimally invasive cardiothoracic surgery, published 2013 to 2024.
- Chest wall blocks and erector spinae plane blocks were compared with sham, no block, local infiltration, or neuraxial techniques.
- Chest wall blocks reduced 24-hour pain scores and opioid use versus sham or no block, and erector spinae plane blocks showed similar effects to chest wall blocks.
- The authors conclude that nerve blocks give modest pain and opioid reductions with a favorable safety profile, though adverse events were rare and inconsistently defined.
- Systematic review of case reports and case series covering 31 patients from 28 studies who underwent hepatectomy after Fontan surgery.
- Open or laparoscopic hepatectomy, mostly for hepatocellular carcinoma, with outcomes summarized by hemodynamic strategy such as baseline-CVP targeting and low-pressure pneumoperitoneum.
- No perioperative deaths were reported, but inferior vena cava clamping was linked to significant hypotension and median blood loss was 1,106 mL (range 10-4,130 mL).
- Congestion-related complications such as ascites and pleural effusion were most common postoperatively, and the authors judge hepatectomy feasible in carefully selected patients while noting that risk stratification and hemostatic approaches remain unresolved.
- Systematic review of 207 randomized controlled trials including 63,785 adults undergoing cardiac surgery, evaluating 55 pharmacological and non-pharmacological interventions to prevent cardiac surgery-associated acute kidney injury.
- Most included trials were small (median sample size 120) and single-center (76.7%), and most reported neutral results (149 of 206).
- Dexmedetomidine (OR 0.48, 95% CI 0.29-0.80), fenoldopam (OR 0.57, 95% CI 0.33-0.98), nitric oxide (OR 0.61, 95% CI 0.43-0.88), and remote ischemic preconditioning (OR 0.78, 95% CI 0.67-0.90) were associated with lower odds of CSA-AKI.
- The authors conclude that only a limited number of interventions were associated with lower odds of CSA-AKI and that these findings need cautious interpretation and confirmation in adequately powered RCTs.
- Systematic review and meta-analysis of 4 RCTs (7 reports, 446 randomized adults) comparing perioperative subcutaneous liraglutide with placebo or insulin-based usual care in cardiac surgery.
- Liraglutide was compared with placebo or insulin usual care, with glycemic efficacy and hypoglycemia risk as the central questions.
- Liraglutide did not change 30-day mortality (1/161 vs 3/160; RR 0.42, 95% CI 0.06-2.81) or the composite postoperative complication outcome (RR 0.92, 95% CI 0.74-1.14).
- Hypoglycemia was similar (8/165 vs 9/166; RR 0.85, 95% CI 0.34-2.13), and nausea/vomiting estimates were very imprecise (RR 3.01, 95% CI 0.26-35.27).
- Systematic review of four observational studies (n = 2,824) comparing VA-ECMO plus mechanical thrombectomy with VA-ECMO alone in high-risk PE.
- Only two studies (n = 47) supplied extractable count data, so the pooled estimates rest on very few patients.
- Pooled ORs for in-hospital mortality (0.36; 95% CI, 0.01-13.59) and 90-day mortality (0.43; 95% CI, 0.02-10.66) were imprecise and discordant.
- Neither the nationwide study (aOR 0.75, 95% CI 0.47-1.19) nor the multicenter cohort (HR 0.68, 95% CI 0.45-1.03) reached significance.
- Systematic review and meta-analysis of 163 RCTs and observational studies including 78,053 adults receiving ECMO, with outcomes at 6 months or later.
- Pooled analyses compared long-term mortality across ECMO modalities (venovenous, venoarterial, and extracorporeal CPR) and clinical indications.
- At 1 year, pooled mortality was 37.2% (95% CI, 30.0-45.1%) for venovenous, 55.2% (95% CI, 50.2-60.1%) for venoarterial, and 74.4% (95% CI, 71.4-77.2%) for ECPR.
- Functional outcomes were reported in only 38 of 163 studies and were inconsistent, so the authors call for standardized reporting and benchmarking.
- Systematic review and meta-analysis of nine observational studies (n = 1,855) of patients receiving continuous-flow LVADs.
- No intervention was studied; vasoplegia after implantation was the exposure, assessed for incidence, predictors, and outcomes.
- Vasoplegia occurred in 34.2% of patients (95% CI 26.9%-42.4%) and was linked to higher early mortality, major bleeding, worse long-term survival, and longer stays.
- Male sex and higher BMI were predictors and higher blood pressure was protective, while ICU mortality, acute kidney injury, stroke, and right heart failure did not differ.
- Systematic review and meta-analysis of 15 RCTs including 3,274 older adults undergoing cardiac surgery.
- Perioperative dexmedetomidine was compared with placebo or alternative sedative or analgesic regimens for preventing postoperative delirium.
- Dexmedetomidine lowered postoperative delirium incidence (RR 0.70, 95% CI 0.56 to 0.86, p = 0.001; moderate certainty) but increased reported bradycardia (RR 2.08, 95% CI 1.31 to 3.31).
- The benefit appeared larger against active comparators than placebo or saline. The delirium duration reduction (MD -1.12 days) was low certainty with high heterogeneity.
- Systematic review and meta-analysis of 12 RCTs including 713 adult cardiac surgery patients undergoing cardiopulmonary bypass.
- Compared intraoperative haemoadsorption inserted into the bypass circuit with conventional bypass without haemoadsorption.
- No significant mortality benefit was found (OR 1.08, 95% CI 0.59-2.01, P=0.75), and no significant difference in hospital or ICU length of stay.
- Authors conclude there was no evidence of clinical benefit for routine use, but clinically relevant benefit or harm cannot be excluded, and only one included study had low risk of bias.
- This systematic review and meta-analysis pooled 16 retrospective studies of 3,121 durable LVAD insertions, with risk of bias assessed using the Newcastle-Ottawa Scale.
- Vasoplegic syndrome was studied in LVAD insertions performed via cardiopulmonary bypass, with a pooled incidence of 36.30% (95% CI 34.61%-38.02%).
- Reported risk factors included male sex (RR 1.65, p = 0.008), INTERMACS profile ≤2 (RR 1.19, p = 0.009), repeat sternotomy, concomitant procedures, and longer bypass time (WMD 13.17 minutes).
- Vasoplegic syndrome was associated with more right ventricular failure, renal replacement therapy, bleeding reoperation, and higher 30-day mortality (14.85% vs 5.63%, p < 0.001).
- Systematic review and Bayesian network meta-analysis of 13 studies, covering 54 models and 927,113 patients undergoing non-cardiac surgery.
- Machine learning models were compared with the Revised Cardiac Risk Index, analysing the best and worst version of each model type.
- Automated machine learning ranked highest (SUCRA 96.6; best-version MD 0.28, 95%CrI 0.16-0.40), and gradient boosting also outperformed the Revised Cardiac Risk Index (MD 0.20, 95%CrI 0.14-0.26).
- The authors conclude that most machine learning models discriminate better than traditional scores, but none were externally validated, only six had low risk of bias, and prospective multicentre evaluation is needed.
- Systematic review and meta-analysis of 20 studies including nearly 800,000 adult cardiac surgery patients.
- Compared ultra-fast-track extubation (in the OR or within 1 hour) with fast-track extubation (within 6 hours in the ICU).
- UFTE was linked to lower 30-day mortality (OR 0.54), shorter ICU stay (MD -12.27 hours) and shorter hospital stay (MD -1.19 days).
- In propensity-matched cohorts, mortality and reintubation were comparable, though shorter stays persisted, and the authors call for randomized trials.
- Systematic review of five studies including 1,196 adults receiving venoarterial ECMO, published 2000 to 2022, with patients grouped by BMI.
- Compared mortality between patients with BMI <30 and those with BMI ≥30, using a χ2 analysis across pooled studies.
- Mortality was 60.3% for BMI <30 and 58.6% for BMI ≥30 (p = 0.6), and four of five cohorts found no BMI-mortality association.
- The authors conclude obesity alone should not preclude VA-ECMO, but note the data are limited, heterogeneous, and call for caution.
- Systematic review and meta-analysis of 20 studies including 19,918 patients undergoing lung resection surgery.
- Evaluated goal-directed fluid therapy as a preventive strategy and linked acute kidney injury to postoperative outcomes.
- Pooled AKI incidence was 5.31% (95% CI, 3.61%-6.70%); AKI was tied to longer stay (MD 0.92 days; 95% CI, 0.52-1.30) and short-term mortality (RR 5.60; 95% CI, 1.66-18.83).
- Goal-directed fluid therapy did not significantly reduce AKI risk (RR 0.64; 95% CI, 0.32-1.27), and the authors call AKI a prognostic indicator warranting early risk stratification.
- Systematic review and meta-analysis of 8 ICU studies with 601 ECMO patients (venovenous and venoarterial) from multiple international centers.
- Compared conservative heparin anticoagulation (aPTT 40-60 seconds, or none) with standard heparin (aPTT 60-80 seconds).
- Major bleeding was lower with conservative strategies (29.5% vs 52.9%; OR 0.40, 95% CI 0.18-0.91; p = 0.03; I² = 72%), while mortality was similar (OR 1.04, 95% CI 0.53-2.05).
- Authors describe a potential association with fewer bleeding events and no clear increase in mortality or thrombotic complications, but caution that null findings do not establish equivalence.
- Systematic review and meta-analysis of 9 randomized controlled trials with 672 patients undertaking VATS, drawn from 31 identified studies.
- Intravenous lidocaine was compared with control, with bolus and infusion regimens varying across trials.
- Lidocaine did not reduce 24-hour (5 trials, n = 328) or 48-hour (3 trials, n = 242) postoperative morphine use, or pooled movement pain scores.
- Lidocaine significantly reduced postoperative nausea and vomiting across 5 trials (n = 360) with negligible heterogeneity, and the authors judged it safe.
- Systematic review and meta-analysis of 16 randomized controlled trials including 1133 patients undergoing cardiac surgery with cardiopulmonary bypass.
- Compared intraoperative hemoadsorption using sorbent devices during bypass with bypass conducted without hemoadsorption.
- Hemoadsorption significantly reduced acute kidney injury incidence (RR 0.75; 95% CI 0.59-0.96; p = 0.020).
- Renal replacement therapy, mortality and secondary outcomes showed no significant differences, and the authors call for studies on clinical relevance and patient selection.